Calumet, Inc. (NASDAQ:CLMT - Get Free Report) has received a consensus recommendation of "Hold" from the six research firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $37.75.
Several research firms recently weighed in on CLMT. Weiss Ratings raised Calumet from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Monday, May 11th. The Goldman Sachs Group boosted their target price on Calumet from $36.00 to $40.00 and gave the stock a "neutral" rating in a research report on Thursday, July 30th. Finally, TD Cowen reissued a "hold" rating on shares of Calumet in a report on Wednesday, June 3rd.
Get Our Latest Stock Report on CLMT
Calumet Trading Down 5.7%
Shares of CLMT opened at $39.48 on Friday. The firm's 50-day moving average is $37.98 and its two-hundred day moving average is $32.63. Calumet has a twelve month low of $12.94 and a twelve month high of $45.20. The firm has a market capitalization of $3.44 billion, a P/E ratio of -18.28 and a beta of 0.71.
Calumet (NASDAQ:CLMT - Get Free Report) last issued its earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($1.16). The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.12 billion. During the same period in the previous year, the business posted ($1.70) earnings per share. The company's quarterly revenue was up 40.8% compared to the same quarter last year. Analysts predict that Calumet will post -0.13 EPS for the current year.
Insider Activity
In other Calumet news, major shareholder Group Heritage sold 626,998 shares of the stock in a transaction on Friday, May 15th. The stock was sold at an average price of $32.54, for a total transaction of $20,402,514.92. Following the transaction, the insider owned 12,980,211 shares of the company's stock, valued at $422,376,065.94. This represents a 4.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Daniel J. Sajkowski sold 4,240 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total value of $153,318.40. Following the completion of the transaction, the director directly owned 77,718 shares in the company, valued at $2,810,282.88. This trade represents a 5.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 3.15% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in CLMT. Islay Capital Management LLC acquired a new stake in Calumet in the fourth quarter worth $25,000. Aster Capital Management DIFC Ltd increased its holdings in shares of Calumet by 294.7% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company's stock worth $33,000 after acquiring an additional 1,229 shares during the period. Global Retirement Partners LLC bought a new stake in Calumet in the 4th quarter valued at about $34,000. Covestor Ltd lifted its position in Calumet by 29.1% in the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company's stock valued at $43,000 after purchasing an additional 492 shares during the last quarter. Finally, Advisory Services Network LLC bought a new position in Calumet in the 3rd quarter worth about $59,000. 34.41% of the stock is owned by institutional investors and hedge funds.
About Calumet
(
Get Free Report)
Calumet Specialty Products Partners, L.P. NASDAQ: CLMT is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet's product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.